Sermorelina: what it is and what the evidence says
An analog studied for its relationship with natural growth-hormone release via the hypothalamic axis.
Last reviewed: August 16, 2026 · How we verify this
The ground it plays on
Hormones work in axes: a signal from the brain tells a gland to release another hormone, and so on down the chain, with brakes that shut the process off. Intervening at one point has consequences both upstream and downstream. That is why this is the group where professional assessment stops being a recommendation and becomes essential.
What it is studied for
Recovery, sleep, vitality, composition.
There is a distinction that almost always gets lost. A compound being studied for something is not the same as achieving it. And even where it works in a dish or in a mouse, that says little about whether it works in a person or whether the benefit is worth the risk. The section below therefore carries more weight than everything above it.
What the human evidence says
It did have real clinical use: as GHRH(1-29)NH2 it was approved and was studied in randomized multicenter trials for GH deficiency in children and as a diagnostic test, along with trials in older adults that showed increases in GH and IGF-1.
The limitation that matters most
It was withdrawn from the market for commercial reasons, its efficacy on growth was inferior to recombinant GH, and it depends on a functioning pituitary. Its current use in anti-aging clinics is off-label and relies on compounded formulations with no trial support.
Regulatory status
It was approved (Geref) and later withdrawn from the market for commercial reasons. Its current use in anti-aging clinics is off-label and relies on compounded formulations.
Status can change and varies by country. Always verify the rules in force where you live before drawing conclusions.
Cautions and context
Affects hormonal axes; variable individual response.
Requires professional assessment, especially in adults with underlying conditions.
What this page cannot give you
A reference page can take you this far. You know what Sermorelina is and where its research stands, which already puts you ahead of most readers. Four questions remain that no encyclopedia can answer for you, because the answers depend on your own situation:
- What would you measure beforehand, so that later you could tell whether anything actually changed?
- What would you watch along the way, and how consistently?
- What would you ask a professional, and in how much detail, so you do not walk out with a textbook answer?
- What would make you stop?
That is what the course is for
PeptiXtreme is ${CIF.LECCIONES} lessons that hand out no numbers. Each one ends with your starting point, what to watch along the way, the specific questions you take to a professional and the signals that mean stop. It includes per-module exams, a diploma with a verifiable folio, a record to track how you progress, and a human advisor you can actually write to.
See the course → Or measure your judgment, freeReferences
Every entry links to its record on PubMed, the US National Library of Medicine database. Open them and check. We would rather have a reader who verifies than one who takes our word for it.
- Once daily subcutaneous growth hormone-releasing hormone therapy accelerates growth in growth hormone-deficient children during the first year of therapy. Geref International Study Grouphuman J Clin Endocrinol Metab · 1996 · PMID 8772599 →
- A comparative study of growth hormone (GH) and GH-releasing hormone(1-29)-NH2 for stimulation of growth in children with GH deficiencyhuman Acta Paediatr Suppl · 1993 · PMID 8329830 →
- Intranasal administration of growth hormone-releasing hormone(1-29)-NH2 in children with growth hormone deficiency: effects on growth hormone secretion and growthhuman Acta Paediatr Suppl · 1993 · PMID 8329828 →
- Endocrine and metabolic effects of long-term administration of [Nle27]growth hormone-releasing hormone-(1-29)-NH2 in age-advanced men and womenhuman J Clin Endocrinol Metab · 1997 · PMID 9141536 →
- Growth hormone (GH)-releasing hormone-(1-29) twice daily reverses the decreased GH and insulin-like growth factor-I levels in old menhuman J Clin Endocrinol Metab · 1992 · PMID 1379256 →
- Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone deficiencyreview BioDrugs · 1999 · PMID 18031173 →
- Sermorelin: a better approach to management of adult-onset growth hormone insufficiency?review Clin Interv Aging · 2006 · PMID 18046908 →
Was this page useful?
Research moves, and when something relevant changes we update the page. If you want to hear about it for Sermorelina or any other compound, leave your email. The introductory guide comes with it. No spam, no list-selling; one click to unsubscribe.
Frequently asked questions
What is Sermorelina?
An analog studied for its relationship with natural growth-hormone release via the hypothalamic axis. It is studied within the area of hormonal/sexual.
Is there human evidence for Sermorelina?
It did have real clinical use: as GHRH(1-29)NH2 it was approved and was studied in randomized multicenter trials for GH deficiency in children and as a diagnostic test, along with trials in older adults that showed increases in GH and IGF-1.
Is it approved by any health agency?
It was approved (Geref) and later withdrawn from the market for commercial reasons. Its current use in anti-aging clinics is off-label and relies on compounded formulations.
What is the dose of Sermorelina?
We do not publish dosages. This is not an oversight. No single figure works for everyone: the regimen depends on a person's medical history, on whatever medication they already take, and on the goal they are chasing, which is something a professional weighs with the case in front of them. What you can build is the ability to walk into that appointment knowing what to ask.
Where can I learn to evaluate this properly?
This page tells you what Sermorelina is and what the evidence says. The PeptiXtreme course teaches the other half: what you would measure before considering anything, what you would watch, the specific questions you would take to a professional and when you would stop.